Theratechnologies Inc T.TH

Alternate Symbol(s): THTX

Healthcare Biotechnology

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. It blocks viral entry into host cells while preserving normal immunologic function. The Company is also investigating an intramuscular method of administration of Trogarzo. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy.

TSX:TH - Post by User

Theratechnologies Inc > Exciting times

<< Previous

Bullboard Posts

Next >>

Post by Trogarzonon Feb 09, 2024 11:34am

113 Views

Post# 35872411

Exciting times

We can feel the market excitement for this story.. pipeline deals, product acquisition, impoving sales, BOD nominations, insider buying. Exciting times ain't it. Waited 25 years for this glorious day to come. A roundtrip to zero.

<< Previous

Bullboard Posts

Next >>

Drilling company poised to capitalize on market conditions